An interventional study of MBSR and NLP in Breastfeeding, Exclusive, Fatigue and Sleep, sponsored by Aysegul Kilicli. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 19 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.
Sponsored by Aysegul Kilicli · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 274 studies in Breast Feeding with a site in Turkey — 68 open to participants now, 77 under way, none of them phase 3. Breast Feeding · Turkey.
Among the 274 studies in Breast Feeding with a site in Turkey, this one is the 93rd largest by enrollment of the 252 interventional ones that give a count, is one of 52 that started in 2024, is one of 251 with no phase, and was the 150th registered.
1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.
Browse Breast Feeding studies →68 of the 274 studies in Breast Feeding with a site in Turkey are open now. Recruiting first, the newest first:
Istanbul University - Cerrahpasa · Sites in Turkey
Ages 18+ · Women only · Healthy volunteers
Karadeniz Technical University · Sites in Turkey
Ages 18+ · Women only · Healthy volunteers
Emel GÜÇLÜ CİHAN · Sites in Turkey
Ages 18–35 · Women only · Healthy volunteers
Aydin Adnan Menderes University · Sites in Turkey
Ages 18–49 · Women only · Healthy volunteers
Inonu University · Sites in Turkey
Ages 18–45 · Women only
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.
This study: 19 Years to 35 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
274 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 52 started in 2024.
This study's enrollment of 90 is close to the median of 100 across 846 interventional studies indexed under Breast Feeding.
Median enrollment 80 across the 252 interventional studies, 163 across the 22 observational. Of the 179 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 274 has an industry lead sponsor. The 10 most frequent:
Aysegul Kilicli is the lead sponsor of 6 studies on the registry; 2 are open to participants now.
Aysegul Kilicli has 2 studies filed under Breast Feeding — fewer than ten, so there is no comparison to draw.
19 of the studies in Breast Feeding with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07656207Gaziantep Islam Science and Technology UniversityThe Effect of Skin-to-skin Contact at Birth | 2026-12 |
| NCT07800078Özlem Ülkü BULUTEvaluation of a Wearable Technology to Support Breastfeeding Women | 2026-12-01 |
| NCT07864753Balikesir UniversityEVALUATION OF TWO MIDWIFE-SUPPORTED BREASTFEEDING POSITIONS DURING THE FIRST BREASTFEEDING FOLLOWING VAGINAL BIRTH | 2026-12-30 |
| NCT07899593Karadeniz Technical UniversityEffect of Solution-Focused Approach Education on Breastfeeding Avoidance and Breastfeeding Self-Efficacy in Primiparous Mothers | 2026-12-31 |
| NCT07396415Marmara UniversityTelehealth-Supported Breastfeeding Counseling in Primiparous Mothers | 2027-01-25 |
Add all 19 to your calendar (.ics) → With an account.
Among the 274 studies in Breast Feeding with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The postnatal period is a risky period in which mothers experience regressive and progressive changes and rapid biopsychosocial changes. Since this process affects not only the mother but also the family, mothers are under intense stress due to adaptation to the changes that occur in this period.
The postnatal period is a risky period in which retrogressive and progressive changes and rapid biopsychosocial changes occur in mothers. Since this process affects not only the mother but also the family, mothers are under intense stress due to adaptation to the changes occurring in this period. Studies have reported that the most common physical problems in the early postpartum period after caesarean section are pain in the incision area, difficulty in caring for the baby alone, activity intolerance, fatigue, insomnia, breastfeeding problems (such as nipple or lack of milk), mastitis and abdominal tension/gas. As important as it is to reduce postpartum symptoms after caesarean section, it is also important to support and maintain breastfeeding. However, postpartum symptoms such as pain, fatigue and negative effects of anaesthesia after caesarean section negatively affect the breastfeeding process and lead to a delay in the onset of lactation.
When the literature was examined, no study was found that examined the effects of mindfulness-based stress reduction programme and neurolinguistic programme on fatigue, sleep quality, lactation and depression in the postpartum long term.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
MBSR; Mindfulness-based stress reduction program. 8 weeks of practice once a week for 20 minutes each. Mindfulness-based stress reduction practices will be carried out online. Mothers will actively participate.
Behavioral: MBSR
NLP; Neurolinguistic programming 8 weeks of practice once a week for 20 minutes each. Neurolinguistic programming will be carried out online. Mothers will actively participate.
Behavioral: NLP
control; MBSR and NLP applications will not be performed. Mothers will be monitored online every week.
Behavioral: control
20 minutes once a week for 8 weeks
Also known as: MBSR mindfulness-based stress reduction program
NLP Neurolinguistic programming, 20 minutes once a week for 8 weeks
Also known as: NLP Neurolinguistic programming
control group, no practice,
Also known as: control group
Visual Analogue Scale for Fatigue (VAS-F)
Visual Analogue Scale for Fatigue (VAS-F), The most positive expression of the fatigue sub-dimension is 0 and the most negative expression is 10, the most negative expression of the energy sub-dimension is 0 and the most positive expression is 10.
Time frame: before the first application
Visual Analogue Scale for Fatigue (VAS-F)
Visual Analogue Scale for Fatigue (VAS-F) The most positive expression of the fatigue sub-dimension is 0 and the most negative expression is 10, the most negative expression of the energy sub-dimension is 0 and the most positive expression is 10.
Time frame: Week 4, following the intervention administered on that day
Visual Analogue Scale for Fatigue (VAS-F)
Visual Analogue Scale for Fatigue (VAS-F) The most positive expression of the fatigue sub-dimension is 0 and the most negative expression is 10, the most negative expression of the energy sub-dimension is 0 and the most positive expression is 10.
Time frame: Week 8, following the final intervention
Pittsburgh Sleep Quality Index (PSQI)
Pittsburgh Sleep Quality Index (PSQI) Each item is evaluated as 0-3 points and the sum of the 7 subcomponents constitutes the PDQI score. The lowest score of the scale is 0 and the highest score is 21. A total PDQI score of ≤5 indicates good sleep and \>5 indicates poor sleep.
Time frame: before the first application
Pittsburgh Sleep Quality Index (PSQI)
Pittsburgh Sleep Quality Index (PSQI) Each item is evaluated as 0-3 points and the sum of the 7 subcomponents constitutes the PDQI score. The lowest score of the scale is 0 and the highest score is 21. A total PDQI score of ≤5 indicates good sleep and \>5 indicates poor sleep.
Time frame: week 4, following the intervention administered on that day
Pittsburgh Sleep Quality Index (PSQI)
Pittsburgh Sleep Quality Index (PSQI) Each item is evaluated as 0-3 points and the sum of the 7 subcomponents constitutes the PDQI score. The lowest score of the scale is 0 and the highest score is 21. A total PDQI score of ≤5 indicates good sleep and \>5 indicates poor sleep.
Time frame: week 8, , following the final intervention
Edinburgh Postpartum Depression Scale (EPDS)
Edinburgh Postpartum Depression Scale (EPDS) The scale is a 4-point Likert-type scale consisting of 10 items. Responses consisting of four options are scored between 0 and 3. A minimum of 0 and a maximum of 30 points can be obtained from the scale. The cut-off point of the scale is 13 points and above for women and 10 points and above for men, and above this point indicates the presence of depression.
Time frame: before the first application
Edinburgh Postpartum Depression Scale (EPDS)
Edinburgh Postpartum Depression Scale (EPDS) The scale is a 4-point Likert-type scale consisting of 10 items. Responses consisting of four options are scored between 0 and 3. A minimum of 0 and a maximum of 30 points can be obtained from the scale. The cut-off point of the scale is 13 points and above for women and 10 points and above for men, and above this point indicates the presence of depression.
Time frame: week 4, following the intervention administered on that day
Edinburgh Postpartum Depression Scale (EPDS)
Edinburgh Postpartum Depression Scale (EPDS) The scale is a 4-point Likert-type scale consisting of 10 items. Responses consisting of four options are scored between 0 and 3. A minimum of 0 and a maximum of 30 points can be obtained from the scale. The cut-off point of the scale is 13 points and above for women and 10 points and above for men, and above this point indicates the presence of depression.
Time frame: week 8, following the final intervention
Breastfeeding Self-Efficacy Scale (BSES)
Breastfeeding Self-Efficacy Scale (BSES) The scale consists of 14 items, five-point Likert type. The items of the scale are evaluated on a scale from '1=never sure' to 5=always sure'. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.
Time frame: before the first application
Breastfeeding Self-Efficacy Scale (BSES)
Breastfeeding Self-Efficacy Scale (BSES) The scale consists of 14 items, five-point Likert type. The items of the scale are evaluated on a scale from '1=never sure' to 5=always sure'. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.
Time frame: week 4, following the intervention administered on that day
Breastfeeding Self-Efficacy Scale (BSES)
Breastfeeding Self-Efficacy Scale (BSES) The scale consists of 14 items, five-point Likert type. The items of the scale are evaluated on a scale from '1=never sure' to 5=always sure'. A minimum of 14 points and a maximum of 70 points can be obtained from the scale. All items are positive. The higher the score obtained from the scale, the higher the breastfeeding self-efficacy.
Time frame: week 8, following the final intervention
Exclusive breastfeeding status
Exclusive breastfeeding status (yes or no)
Time frame: before the first application
Exclusive breastfeeding status
Exclusive breastfeeding status (yes or no)
Time frame: week 4, following the intervention administered on that day
Exclusive breastfeeding status
Exclusive breastfeeding status (yes or no)
Time frame: week 8, following the final intervention
Plan to share: Yes — All
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: 8 October 2024 - 30 October 2025
Access criteria: 8 October 2024 - 30 October 2025
No publications or documents are linked to this record.
Ran from Oct 2024 to primary completion in Feb 2025, 3 months.
Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 3 months is below that.
Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Oct 2025 → Feb 2025 and completion Oct 2025 → Feb 2025.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Aysegul Kilicli